Tag:
deforolimus
Latest Headlines
Latest Headlines
Ariad merges with subsidary
Ariad Pharmaceuticals has announced that it will merge with its 80 percent-owned subsidiary Ariad Gene Therapeutics (AGTI). "Based on our evaluation, we believe that this is an appropriate time to
